64 related articles for article (PubMed ID: 11748757)
1. Macrogol 3350/electrolyte improves constipation in Parkinson's disease and multiple system atrophy.
Eichhorn TE; Oertel WH
Mov Disord; 2001 Nov; 16(6):1176-7. PubMed ID: 11748757
[TBL] [Abstract][Full Text] [Related]
2. Body-first versus brain-first biological subtyping of Parkinson's disease.
Bohnen NI; Postuma RB
Brain; 2020 Oct; 143(10):2871-2873. PubMed ID: 33103732
[TBL] [Abstract][Full Text] [Related]
3. Macrogol for the treatment of constipation in Parkinson's disease. A randomized placebo-controlled study.
Zangaglia R; Martignoni E; Glorioso M; Ossola M; Riboldazzi G; Calandrella D; Brunetti G; Pacchetti C
Mov Disord; 2007 Jul; 22(9):1239-44. PubMed ID: 17566120
[TBL] [Abstract][Full Text] [Related]
4. Management of constipation in Parkinson's disease.
Rossi M; Merello M; Perez-Lloret S
Expert Opin Pharmacother; 2015 Mar; 16(4):547-57. PubMed ID: 25539892
[TBL] [Abstract][Full Text] [Related]
5. Placebo-controlled trial of lubiprostone for constipation associated with Parkinson disease.
Ondo WG; Kenney C; Sullivan K; Davidson A; Hunter C; Jahan I; McCombs A; Miller A; Zesiewicz TA
Neurology; 2012 May; 78(21):1650-4. PubMed ID: 22573627
[TBL] [Abstract][Full Text] [Related]
6. Tegaserod (Zelnorm) for the treatment of constipation in Parkinson's disease.
Sullivan KL; Staffetti JF; Hauser RA; Dunne PB; Zesiewicz TA
Mov Disord; 2006 Jan; 21(1):115-6. PubMed ID: 16142776
[TBL] [Abstract][Full Text] [Related]
7. Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation.
Attar A; Lémann M; Ferguson A; Halphen M; Boutron MC; Flourié B; Alix E; Salmeron M; Guillemot F; Chaussade S; Ménard AM; Moreau J; Naudin G; Barthet M
Gut; 1999 Feb; 44(2):226-30. PubMed ID: 9895382
[TBL] [Abstract][Full Text] [Related]
8. Lactulose versus Polyethylene Glycol for Chronic Constipation.
Lee-Robichaud H; Thomas K; Morgan J; Nelson RL
Cochrane Database Syst Rev; 2010 Jul; (7):CD007570. PubMed ID: 20614462
[TBL] [Abstract][Full Text] [Related]
9. Non-pharmacological and drug treatment of autonomic dysfunction in multiple system atrophy: current status and future directions.
Chen B; Yang W; Luo Y; Tan EK; Wang Q
J Neurol; 2023 Nov; 270(11):5251-5273. PubMed ID: 37477834
[TBL] [Abstract][Full Text] [Related]
10. Gastrointestinal Dysfunction in Parkinson's Disease: Neuro-Gastroenterology Perspectives on a Multifaceted Problem.
Tan AH; Chuah KH; Beh YY; Schee JP; Mahadeva S; Lim SY
J Mov Disord; 2023 May; 16(2):138-151. PubMed ID: 37258277
[TBL] [Abstract][Full Text] [Related]
11. Gastrointestinal Dysfunction in Parkinson's Disease: Current and Potential Therapeutics.
Han MN; Finkelstein DI; McQuade RM; Diwakarla S
J Pers Med; 2022 Jan; 12(2):. PubMed ID: 35207632
[TBL] [Abstract][Full Text] [Related]
12. Gastrointestinal Dysfunction in Parkinson's Disease.
Safarpour D; Sharzehi K; Pfeiffer RF
Drugs; 2022 Feb; 82(2):169-197. PubMed ID: 35076890
[TBL] [Abstract][Full Text] [Related]
13. Gastrointestinal dysfunction in the synucleinopathies.
Chung KA; Pfeiffer RF
Clin Auton Res; 2021 Feb; 31(1):77-99. PubMed ID: 33247399
[TBL] [Abstract][Full Text] [Related]
14. Current Concepts in the Treatment of Multiple System Atrophy.
Perez-Lloret S; Flabeau O; Fernagut PO; Pavy-Le Traon A; Rey MV; Foubert-Samier A; Tison F; Rascol O; Meissner WG
Mov Disord Clin Pract; 2015 Mar; 2(1):6-16. PubMed ID: 30363880
[TBL] [Abstract][Full Text] [Related]
15. Management of constipation in patients with Parkinson's disease.
Pedrosa Carrasco AJ; Timmermann L; Pedrosa DJ
NPJ Parkinsons Dis; 2018; 4():6. PubMed ID: 29560414
[TBL] [Abstract][Full Text] [Related]
16. Current trends in etiology, prognosis and therapeutic aspects of Parkinson's disease: a review.
Jagadeesan AJ; Murugesan R; Vimala Devi S; Meera M; Madhumala G; Vishwanathan Padmaja M; Ramesh A; Banerjee A; Sushmitha S; Khokhlov AN; Marotta F; Pathak S
Acta Biomed; 2017 Oct; 88(3):249-262. PubMed ID: 29083328
[TBL] [Abstract][Full Text] [Related]
17. Gastrointestinal Dysfunctions in Parkinson's Disease: Symptoms and Treatments.
Poirier AA; Aubé B; Côté M; Morin N; Di Paolo T; Soulet D
Parkinsons Dis; 2016; 2016():6762528. PubMed ID: 28050310
[TBL] [Abstract][Full Text] [Related]
18. Current Treatment of Multiple System Atrophy.
Maaß S; Levin J; Höglinger G
Curr Treat Options Neurol; 2016 Dec; 18(12):51. PubMed ID: 27787721
[TBL] [Abstract][Full Text] [Related]
19. The option of sonographic guidance in Botulinum toxin injection for drooling in Parkinson's disease.
Jost WH
J Neural Transm (Vienna); 2016 Jan; 123(1):51-5. PubMed ID: 26138438
[TBL] [Abstract][Full Text] [Related]
20. [Gastrointestinal dysfunction in idiopathic Parkinson's disease].
Del Tredici K; Jost WH
Nervenarzt; 2012 Oct; 83(10):1282-91. PubMed ID: 22743836
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
